These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4036118)

  • 21. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
    Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
    Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.
    van Milligen de Wit AW; van Deventer SJ; Tytgat GN
    Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary sclerosing cholangitis--an ulcerative colitis-associated illness with surgical consequences].
    Heuschen G; Heuschen UA; Herfarth C
    Chirurg; 1998 Oct; 69(10):1028-34. PubMed ID: 9833181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of primary sclerosing cholangitis with HLA-B8.
    Chapman RW; Varghese Z; Gaul R; Patel G; Kokinon N; Sherlock S
    Gut; 1983 Jan; 24(1):38-41. PubMed ID: 6600227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sclerosing cholangitis associated with chronic cryptosporidiosis in a child with a congenital immunodeficiency disorder.
    Davis JJ; Heyman MB; Ferrell L; Kerner J; Kerlan R; Thaler MM
    Am J Gastroenterol; 1987 Nov; 82(11):1196-202. PubMed ID: 3674002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.
    Mehal WZ; Lo YM; Wordsworth BP; Neuberger JM; Hubscher SC; Fleming KA; Chapman RW
    Gastroenterology; 1994 Jan; 106(1):160-7. PubMed ID: 8276178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial primary biliary cirrhosis and autoimmune cholangitis.
    Agarwal K; Jones DE; Watt FE; Burt AD; Floreani A; Bassendine MF
    Dig Liver Dis; 2002 Jan; 34(1):50-2. PubMed ID: 11930900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ulcerative colitis associated with IgG4 cholangitis: similar features in two HLA identical siblings.
    Dastis SN; Latinne D; Sempoux C; Geubel AP
    J Hepatol; 2009 Sep; 51(3):601-5. PubMed ID: 19615774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into autoimmune cholangitis through animal models.
    Trauner M; Fickert P; Baghdasaryan A; Claudel T; Halilbasic E; Moustafa T; Wagner M; Zollner G
    Dig Dis; 2010; 28(1):99-104. PubMed ID: 20460897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatobiliary diseases in Crohn disease and ulcerative colitis].
    Kruis W
    Leber Magen Darm; 1987 Feb; 17(1):28, 31-2, 35-6. PubMed ID: 3561141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to carbonic anhydrase in patients with immune cholangiopathies.
    Gordon SC; Quattrociocchi-Longe TM; Khan BA; Kodali VP; Chen J; Silverman AL; Kiechle FL
    Gastroenterology; 1995 Jun; 108(6):1802-9. PubMed ID: 7768386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiology and pathogenesis in primary sclerosing cholangitis.
    Boberg KM; Lundin KE; Schrumpf E
    Scand J Gastroenterol Suppl; 1994; 204():47-58. PubMed ID: 7824878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium.
    Mandal A; Dasgupta A; Jeffers L; Squillante L; Hyder S; Reddy R; Schiff E; Das KM
    Gastroenterology; 1994 Jan; 106(1):185-92. PubMed ID: 7506217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated circulating immune complexes in primary sclerosing cholangitis.
    Bodenheimer HC; LaRusso NF; Thayer WR; Charland C; Staples PJ; Ludwig J
    Hepatology; 1983; 3(2):150-4. PubMed ID: 6832707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis.
    Ludwig J; Barham SS; LaRusso NF; Elveback LR; Wiesner RH; McCall JT
    Hepatology; 1981; 1(6):632-40. PubMed ID: 7308996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of immune factors in the pathogenesis of primary sclerosing cholangitis.
    Chapman RW
    Semin Liver Dis; 1991 Feb; 11(1):1-4. PubMed ID: 2047883
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis.
    Muratori P; Muratori L
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):e47. PubMed ID: 28566131
    [No Abstract]   [Full Text] [Related]  

  • 38. Etiopathogenesis of primary sclerosing cholangitis.
    Chapman R; Cullen S
    World J Gastroenterol; 2008 Jun; 14(21):3350-9. PubMed ID: 18528932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopathogenesis of primary sclerosing cholangitis.
    Worthington J; Cullen S; Chapman R
    Clin Rev Allergy Immunol; 2005 Apr; 28(2):93-103. PubMed ID: 15879616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ulcerative colitis associated with primary biliary cirrhosis.
    Koulentaki M; Koutroubakis IE; Petinaki E; Tzardi M; Oekonomaki H; Mouzas I; Kouroumalis EA
    Dig Dis Sci; 1999 Oct; 44(10):1953-6. PubMed ID: 10548342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.